EP
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ·Healthcare·Biotechnology
$7.11
-1.46%
Mkt Cap $261.81M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.16 | -$0.37 | -131.25% | — | — |
| Q4 2025 Nov 4, 2025 | — | — | — | -$0.23 | -$0.19 | +17.39% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.21 | -$0.26 | -23.81% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$0.19 | -$0.21 | -10.53% | — | — |
| Q1 2025 Mar 20, 2025 | — | — | — | -$0.18 | -$0.21 | -16.67% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.13 | -$0.17 | -30.05% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.17 | -$0.17 | -0.37% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.17 | -$0.21 | -23.25% | — | — |
| Q1 2024 Mar 21, 2024 | — | $2.98M | — | — | -$0.15 | — | — | — |
| Q3 2023 Sep 30, 2023 | — | — | — | -$0.11 | -$0.25 | -124.05% | — | — |
| Q2 2023 Jun 30, 2023 | — | — | — | -$0.27 | -$0.36 | -30.95% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.17 | -$0.23 | -34.38% | — | — |
| Q4 2022 Dec 31, 2022 | $8.48M | — | — | -$0.13 | -$0.41 | -225.81% | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | -$0.31 | -$0.22 | +29.96% | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | -$0.30 | -$0.31 | -3.72% | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.26 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | -$0.27 | -$0.30 | -10.30% | — | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.35 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.41 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$1.13 | — | — | — |